血栓通联合吡拉西坦治疗老年性脑梗死后遗症的临床疗效观察

Observation of clinical effect by Xueshuantong combined with piracetam in the treatment of senile cerebral infarction sequela

目的研究血栓通联合吡拉西坦治疗老年性脑梗死后遗症的临床疗效。方法 120例老年性脑梗死后遗症患者,随机分为试验组与对照组,各60例。对照组采取吡拉西坦治疗,试验组在对照组的基础上加用血栓通治疗。观察两组患者治疗前后神经功能缺损评分(NIHSS)及简易精神状态评价量表评分(MMSE)。结果两组患者治疗前NIHSS及MMSE评分比较,差异无统计学意义(P>0.05);治疗后,试验组NIHSS及MMSE评分明显优于对照组,差异均具有统计学意义(P<0.05)。结论对于老年性脑梗死后遗症患者采用血栓通联合吡拉西坦治疗可以明显减轻神经功能的缺损,改善精神状态,值得在临床推广。

ObjectiveTo research clinical effect by Xueshuantong combined with piracetam in the treatment of senile cerebral infarction sequela.MethodsA total of 120 senile patients with cerebral infarction sequela were randomly divided into experimental group and control group, with 60 cases in each group. The control group received piracetam for treatment, and the experimental group received additional Xueshuantong. National institutes of health stroke scale （NIHSS） and mini-mental state examination （MMSE） were observed in the two groups before and after treatment.ResultsBefore treatment, there was no statistically significant difference of NIHSS and MMSE scores between the two groups （P〉0.05）. The experimental group had much better NIHSS and MMSE scores after treatment than the control group, and their differences all had statistical significance （P〈0.05）. ConclusionImplement of Xueshuantong combined with piracetam for senile cerebral infarction sequela patients can obviously reduce neurologic impairment and improve mental state. It is worthy of clinical promotion.